<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01914861</url>
  </required_header>
  <id_info>
    <org_study_id>Sheba-0361-13-AJW-CTIL</org_study_id>
    <nct_id>NCT01914861</nct_id>
  </id_info>
  <brief_title>Cortisol Diurnal Variation and the Risk for Developing Post Traumatic Stress Disorder</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine a possible link between the time of day of exposure&#xD;
      to a traumatic event and the risk of developing post-traumatic stress disorder. Clinical and&#xD;
      biological correlates will also be examined from this perspective.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>July 2013</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Development of Posttraumatic stress disorder</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biological correlates of post-traumatic stress disorder</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>correlation between development of Posttraumatice stress disorder and time of traumatic event</measure>
    <time_frame>six months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Posttraumatic Stress Disorders</condition>
  <condition>Cortisol Diurnal Variation</condition>
  <arm_group>
    <arm_group_label>Men/Women, 21-65, following exposure to a traumatice event</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma cortisol levels plasma neuropeptide y&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Men/Women, age 21-65, who have arrived at the Chaim Sheba Medical Center ER within six&#xD;
        hours of exposure to a traumatic event.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Persons 21-65 years old, who have been exposed to an event meeting the following&#xD;
             DSM-IV criterion for Acute Stress Disorder:&#xD;
&#xD;
             Criteria A.1 and A.2 At least one of Criteria B1-5A.1&#xD;
&#xD;
          2. Who provide written, informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Physical injury that would contraindicate participation or interfere with a subject's&#xD;
             ability to give informed consent or cooperate with the screening or collection of&#xD;
             initial measures. Examples include severe burn injury, life-threatening medical or&#xD;
             surgical condition, condition requiring surgical intervention under general&#xD;
             anesthesia, as indicated by Abbreviated Injury Scale (AIS), or by clinical judgment;&#xD;
&#xD;
          2. Head injury involving confusion, loss of consciousness, or amnesia;&#xD;
&#xD;
          3. Medical conditions such as extreme obesity, psoriasis, herpes, Cushing's syndrome,&#xD;
             current infectious disease, current viral disease, tuberculosis, unstable diabetes or&#xD;
             hypertension, myasthenia gravis, and heart failure. Persons taking medications that&#xD;
             can interfere with the HPA axis (e.g.,steroids, betablockers,indomethacin) will be&#xD;
             excluded;&#xD;
&#xD;
          4. Weight below 45 or above 120 kg.&#xD;
&#xD;
          5. Pregnancy (in suggestive cases, a pregnancy test will be performed);&#xD;
&#xD;
          6. Traumatic exposure that reflects ongoing victimization (e.g., domestic violence) to&#xD;
             which the subject is likely to be re-exposed during the study period.&#xD;
&#xD;
          7. Overt psychopathology, intoxication, or under the influence of substances.&#xD;
&#xD;
          8. Evidence or history of schizophrenia, bipolar, other psychotic condition;&#xD;
&#xD;
          9. Prior history of PTSD;&#xD;
&#xD;
         10. Current or past history of dementia, amnesia, or other cognitive disorder predating&#xD;
             trauma exposure;&#xD;
&#xD;
         11. Assessed serious suicide risk. -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alzbeta J Wetzler, MD</last_name>
    <phone>972-3-530-3300</phone>
    <email>Alzbeta.JuvenWetzler@sheba.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Ramat-Gan</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <study_first_submitted>July 31, 2013</study_first_submitted>
  <study_first_submitted_qc>July 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2013</study_first_posted>
  <last_update_submitted>July 31, 2013</last_update_submitted>
  <last_update_submitted_qc>July 31, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

